Abstract:Extracellular vesicles from young sedentary (EV‐C) or exercised (EV‐EX) individuals when delivered to aged subjects protect them from developing advanced liver fibrosis as observed with EV‐A by reducing the activation of HSCs. The mechanism of the fibrosis regression seems to differ between EV‐C and EV‐EX. While EV‐C potentially induces HSC senescence, EV‐EX reduces inflammation and accelerates elastin degradation. The hepatic levels of miR‐30c‐5p were correlated with HSC activation as shown by the protective effect of EV‐miR‐30c in liver fibrosis. Aging is associated with decreased health span, and despite the recent advances made in understanding the mechanisms of aging, no antiaging drug has been approved for therapy. Therefore, strategies to promote a healthy life in aging are desirable. Previous work has shown that chronic treatment with extracellular vesicles (EVs) from young mice prolongs lifespan in old mice, but the mechanism of action of this effect on liver metabolism is not known. Here we investigated the role of treatment with EVs derived from young sedentary (EV‐C) or exercised (EV‐EX) mice in the metabolism of old mice and aimed to identify key youthful‐associated microRNA (miRNA) cargos that could promote healthy liver function. We found that aged mice treated with either EV‐C or EV‐EX had higher insulin sensitivity, higher locomotor activity resulting in longer distance traveled in the cage, and a lower respiratory exchange ratio compared to mice treated with EVs from aged mice (EV‐A). In the liver, treatment with young‐derived EVs reduced aging‐induced liver fibrosis. We identified miR‐30c in the EVs as a possible youth‐associated miRNA as its level was higher in circulating EVs of young mice. Treatment of aged mice with EVs transfected with miR‐30c mimic reduced stellate cell activation in the liver and reduced fibrosis compared to EV‐negative control by targeting Foxo3. Our results suggest that by delivering juvenile EVs to old mice, we can improve their liver health. Moreover, we identified miR‐30c as a candidate for antiaging liver therapy.

Small extracellular vesicles are rejuvenating factors in young blood

Small Extracellular Vesicles from Young Plasma Reverse Age-Related Functional Declines by Improving Mitochondrial Energy Metabolism

Rejuvenating effects of young extracellular vesicles in aged rats and in cellular models of human senescence

Embryonic stem cell-derived extracellular vesicles rejuvenate senescent cells and antagonize aging in mice

Extracellular Vesicles in Young Serum Contribute to the Restoration of Age-Related Brain Transcriptomes and Cognition in Old Mice

Mesenchymal stem cell‐derived extracellular vesicles reduce senescence and extend health span in mouse models of aging

Extracellular vesicle‐encapsulated miR‐30c‐5p reduces aging‐related liver fibrosis

Small extracellular vesicles from young adipose-derived stem cells ameliorate age-related changes in the heart of old mice.

Inducible Pluripotent Stem Cell-Derived Small Extracellular Vesicles Rejuvenate Senescent Blood-Brain Barrier to Protect against Ischemic Stroke in Aged Mice

Distinct immunomodulation elicited by young versus aged extracellular vesicles in bone marrow-derived macrophages

Muscle-derived miR-34a increases with age in circulating extracellular vesicles and induces senescence of bone marrow stem cells

Circulating small extracellular vesicles as blood-based biomarkers of muscle health in aging nonhuman primates

Extracellular Vesicles from Healthy Cells Improves Cell Function and Stemness in Premature Senescent Stem Cells by miR-302b and HIF-1α Activation

Mesenchymal stem cell-derived small extracellular vesicles mitigate oxidative stress-induced senescence in endothelial cells via regulation of miR-146a/Src

Small Extracellular Vesicles Secreted by Urine-Derived Stem Cells Enhanced Wound Healing in Aged Mice by Ameliorating Cellular Senescence

3D ECM-Based Scaffolds Boost Young Cell Secretome-Derived EV Rejuvenating Effects in Senescent Cells

Young small extracellular vesicles rejuvenate replicative senescence by remodeling Drp1 translocation-mediated mitochondrial dynamics

Small Extracellular Vesicles Are Key Regulators of Non-cell Autonomous Intercellular Communication in Senescence via the Interferon Protein IFITM3

Extracellular vesicles deposit PCNA to rejuvenate aged bone marrow–derived mesenchymal stem cells and slow age-related degeneration

Extracellular vesicles from human urine-derived stem cells delay aging through the transfer of PLAU and TIMP1

Small Extracellular Vesicles Maintain Homeostasis of Senescent Mesenchymal Stem Cells at Least Through Excreting Harmful Lipids